liuzhaohui

[liuzhaohui @liuzhaohui15]

@cirujano_cardio @MMarinCuartas @VictorDayan1 @HrisKirov @JMMComendador @pomyers @VDelgadoGarcia @dr_benoy_n_shah @DVervoort94 @TulioCaldonazo Clinical trials like SURTAVI or PARTNER 2 have set follow-up periods due to design constraints and evolving technology. While not disinterested in older TAVI models, focus has shifted to newer devices. Longer follow-ups would indeed be valuable for assessing durability.